Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2025-12-24 @ 3:54 PM
NCT ID:
NCT00336492
Eligibility Criteria:
Inclusion Criteria:
* Have moderately to severely active ulcerative colitis
* Diagnosed with ulcerative colitis for 2 weeks before screening
* Male patients who are sexually active and female patients who are sexually active or of childbearing potential must use adequate birth control while participation in the study and for 6 months after the last infusion.
Exclusion Criteria:
* History of latent or active TB
* Have had a live viral or bacterial vaccination within 3 months before screening
* Have or have had serious infections within 3 months before screening
* Prior treatment with infliximab
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
17 Years
Study:
NCT00336492
Study Brief:
Protocol Section:
NCT00336492